Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic arterial chemoembolization with CDDP microcapsules. Experimental studies.

Y Wang1, M C Wu, X H Zhang

  • 1Institute of Hepatobiliary Surgery, Second Military Medical University, Shanghai.

Chinese Medical Journal
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiota and Intestinal Monodomination as a Predictor for Bacteremia in Allogeneic Hematopoietic Cell Transplant Recipients.

The Journal of infectious diseases·2026
Same author

[The conception and significance of establishing carcinothrombosis].

Zhonghua yi xue za zhi·2020
Same author

Silica-based colloid centrifugation enhances sperm quality in cockerel semen.

British poultry science·2019
Same author

[My road to malaria control: an interview with Li Guoqiao].

Zhonghua yi shi za zhi (Beijing, China : 1980)·2019
Same author

[Progress on surgical treatment of intrahepatic cholangiocarcinoma].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2019
Same author

[Effects of pre-transplant course on prognosis of allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2019

Ethylcellulose microcapsules loaded with cis-diamminedichloroplatinum (CDDPmc) offer improved liver cancer treatment. CDDPmc maintains high drug levels in liver tissue while reducing blood exposure, enhancing therapeutic effects and survival rates.

Area of Science:

  • Pharmacology
  • Oncology
  • Biomedical Engineering

Background:

  • Liver cancer treatment often involves chemotherapy delivered via hepatic arterial infusion.
  • Conventional chemotherapy agents can cause systemic toxicity and have limited efficacy.
  • Novel drug delivery systems are needed to improve targeted drug delivery and therapeutic outcomes.

Purpose of the Study:

  • To evaluate the pharmacokinetic profile and antitumor efficacy of cis-diamminedichloroplatinum ethylcellulose microcapsules (CDDPmc) compared to unencapsulated CDDP.
  • To assess the potential of CDDPmc as an improved dosage form for hepatic arterial infusion in liver cancer treatment.

Main Methods:

  • Pharmacokinetic studies in New Zealand rabbits measuring CDDP concentrations in blood and hepatic tissue after infusion of CDDPmc and unencapsulated CDDP.

Related Experiment Videos

  • Antitumor efficacy evaluation in a rat liver tumor model, comparing CDDPmc, unencapsulated CDDP, and blank microcapsules.

    • Main Results:

    • CDDPmc demonstrated sustained high CDDP concentrations in hepatic tissue for a longer duration compared to unencapsulated CDDP.
    • Maximum CDDP levels in circulating blood were significantly reduced with CDDPmc.
    • CDDPmc showed superior tumoricidal effects, including reduced tumor growth, increased necrosis, and prolonged survival in rats.

    Conclusions:

    • CDDPmc represents a promising drug delivery system for hepatic arterial infusion in liver cancer therapy.
    • The microencapsulation of CDDP enhances its therapeutic index by improving local drug retention and minimizing systemic exposure.
    • CDDPmc offers a potentially more effective and safer treatment option for liver cancer compared to conventional CDDP.